Measuring success of adjuvant treatment for patients with melanoma

Lancet Oncol. 2024 Sep;25(9):1109-1110. doi: 10.1016/S1470-2045(24)00372-3. Epub 2024 Aug 12.

Authors

Brent O'Carrigan¹, Pippa G Corrie²

Affiliations

¹ Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
² Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. Electronic address: [email protected].

PMID: 39146952
DOI: 10.1016/S1470-2045(24)00372-3

No abstract available

Publication types

News

MeSH terms

Chemotherapy, Adjuvant
Humans
Melanoma* / drug therapy
Melanoma* / mortality
Melanoma* / pathology
Skin Neoplasms / drug therapy
Skin Neoplasms / mortality
Skin Neoplasms / pathology
Skin Neoplasms / therapy
Treatment Outcome